Showing 1 - 10 of 191,382
We discuss and review literature on the macroeconomic effects of epidemics and pandemics since the late 20th century. First, we cover the role of health in driving economic growth and well-being and discuss standard frameworks for assessing the economic burden of infectious diseases. Second, we...
Persistent link: https://www.econbiz.de/10012271478
Persistent link: https://www.econbiz.de/10013263336
Persistent link: https://www.econbiz.de/10012316962
Persistent link: https://www.econbiz.de/10012286327
Persistent link: https://www.econbiz.de/10013168113
This research explores the persistent effect of the Neolithic Revolution on the evolution of life expectancy in the course of human history. It advances the hypothesis and establishes empirically that the onset of the Neolithic Revolution and the associated rise in infectious diseases triggered...
Persistent link: https://www.econbiz.de/10013170449
This research explores the persistent effect of the Neolithic Revolution on the evolution of life expectancy in the course of human history. It advances the hypothesis and establishes empirically that the onset of the Neolithic Revolution and the associated rise in infectious diseases triggered...
Persistent link: https://www.econbiz.de/10013171007
This research explores the persistent effect of the Neolithic Revolution on the evolution of life expectancy in the course of human history. It advances the hypothesis and establishes empirically that the onset of the Neolithic Revolution and the associated rise in infectious diseases triggered...
Persistent link: https://www.econbiz.de/10013164530
To assess the efficacy of Covid-19 non-pharmaceutical interventions (NPIs) on infectious disease containment in Europe, we first use weekly 2015-20 data on the spread of influenza and respiratory syncytial virus (RSV) to compare the 2019-20 season of these diseases with the previous five....
Persistent link: https://www.econbiz.de/10012372809
The portfolio approach of financing drug development has been proposed as a financial innovation to improve the risk/return tradeoff of investment in drug development projects through the use of diversification and securitization. By investing in a sizable and well-diversified portfolio of novel...
Persistent link: https://www.econbiz.de/10014343742